THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 117 filers reported holding THERAVANCE INC in Q4 2014. The put-call ratio across all filers is 3.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $217,000 | +46.6% | 20,605 | 0.0% | 0.00% | +100.0% |
Q3 2015 | $148,000 | -60.2% | 20,605 | 0.0% | 0.00% | -66.7% |
Q2 2015 | $372,000 | +14.8% | 20,605 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $324,000 | +11.0% | 20,605 | 0.0% | 0.00% | +50.0% |
Q4 2014 | $292,000 | -17.0% | 20,605 | 0.0% | 0.00% | -33.3% |
Q3 2014 | $352,000 | -42.7% | 20,605 | 0.0% | 0.00% | -40.0% |
Q2 2014 | $614,000 | -14.5% | 20,605 | -11.3% | 0.01% | -16.7% |
Q1 2014 | $718,000 | -13.3% | 23,222 | -0.0% | 0.01% | -14.3% |
Q4 2013 | $828,000 | -12.7% | 23,233 | +0.2% | 0.01% | -22.2% |
Q3 2013 | $948,000 | -6.0% | 23,187 | -11.5% | 0.01% | -10.0% |
Q2 2013 | $1,009,000 | – | 26,187 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baupost Group | 20,395,056 | $607,365,000 | 9.89% |
Realm Partners LLC | 301,521 | $8,979,000 | 3.75% |
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 2,805,837 | $83,558,000 | 2.52% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 7,447,743 | $221,794,000 | 2.27% |
SECTORAL ASSET MANAGEMENT INC | 1,743,188 | $51,912,000 | 2.20% |
Foundation Asset Management, LP | 255,790 | $7,617,000 | 2.19% |
Proxima Capital Management, LLC | 550,000 | $16,379,000 | 1.93% |
Roundview Capital LLC | 140,645 | $4,188,000 | 1.69% |
BB BIOTECH AG | 933,244 | $27,792,000 | 1.32% |
PERRY CAPITAL | 1,517,208 | $45,182,000 | 1.25% |